Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Moderate to Severe Rheumatoid Arthritis”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01960855
What this trial is testing

A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic Therapy

Who this might be right for
Rheumatoid Arthritis
AbbVie 276
Large-scale testing (Phase 3)Study completedNCT00996606
What this trial is testing

Tocilizumab in Combination With Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Moderate to Severe Active Rheumatoid Arthritis With an Inadequate Response to DMARDs

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 58
Testing effectiveness (Phase 2)Study completedNCT00595413
What this trial is testing

Atacicept in Anti-Tumor Necrosis Factor Alpha-naïve Subjects With Rheumatoid Arthritis (AUGUST II)

Who this might be right for
Rheumatoid Arthritis
EMD Serono 311
Large-scale testing (Phase 3)Study completedNCT02720523
What this trial is testing

Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis (RA) Who Are on a Stable Dose of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) and Have an Inadequate Response to csDMARDs

Who this might be right for
Rheumatoid Arthritis
AbbVie 197
Large-scale testing (Phase 3)Study completedNCT02760433
What this trial is testing

Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active Disease

Who this might be right for
Rheumatoid Arthritis
R-Pharm International, LLC 368
Testing effectiveness (Phase 2)Study completedNCT01373151
What this trial is testing

Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate

Who this might be right for
Rheumatoid Arthritis
CSL Behring 418
Large-scale testing (Phase 3)Active Not RecruitingNCT02629159
What this trial is testing

A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
AbbVie 1,629
Large-scale testing (Phase 3)Study completedNCT03052322
What this trial is testing

MSB11022 in Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Moderate to Severe Rheumatoid Arthritis
Fresenius Kabi SwissBioSim GmbH 288
Large-scale testing (Phase 3)Study completedNCT02760407
What this trial is testing

Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease

Who this might be right for
Rheumatoid Arthritis
R-Pharm International, LLC 1,648
Large-scale testing (Phase 3)Study completedNCT00106548
What this trial is testing

Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 623
Large-scale testing (Phase 3)Study completedNCT03478111
What this trial is testing

CMAB008 With MTX Therapy in Adult Patients With Moderately to Severely Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Shanghai Biomabs Pharmaceutical Co., Ltd. 390
Testing effectiveness (Phase 2)Looking for participantsNCT07276581
What this trial is testing

Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
AstraZeneca 320
Post-approval studies (Phase 4)Study completedNCT01010503
What this trial is testing

Tocilizumab With or Without Methotrexate in Patients With Rheumatoid Arthritis.

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 32
Large-scale testing (Phase 3)Study completedNCT01211834
What this trial is testing

Efficacy and Safety of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
JW Pharmaceutical 90
Large-scale testing (Phase 3)Study completedNCT01721057
What this trial is testing

A Study in Moderate to Severe Rheumatoid Arthritis Participants

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 684
Large-scale testing (Phase 3)Study completedNCT00106535
What this trial is testing

Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 1,196
Large-scale testing (Phase 3)Study completedNCT02011334
What this trial is testing

A Study Assessing the Safety and Efficacy of Subcutaneous RoActemra/Actemra Alone or in Combination With Non-biologic Antirheumatics in Rhuematoid Arthritis Patients in Latin America With Inadequate Response to Non-biologic Antirheumatic Drugs.

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 285
Testing effectiveness (Phase 2)Study completedNCT02015520
What this trial is testing

Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
CSL Behring 143
Large-scale testing (Phase 3)Study completedNCT02955212
What this trial is testing

A Study With Upadacitinib (ABT-494) in Subjects From China and Selected Countries With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs)

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 338
Not applicableStudy completedNCT01770834
What this trial is testing

A Prospective, Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 100
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation